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Anaphylaxis or anaphylactoid reaction in pediatric patient during anesthesia is rare. We report a rocuronium induced 
anaphylactic reaction in a 33-month-old female. The patient was scheduled to undergo escharectomy due to injuries 
suffered from a major burn. Shortly after administration of rocuronium, the patient developed severe hypotension, 
tachycardia, and hypoxia. A similar reaction occurred after administration of rocuronium on subsequent anesthesia. 
She underwent uneventful anesthesia with volatile induction and maintenance of anesthesia with sevoflurane on her 
next 7 operations without using of muscle relaxant. (Korean J Anesthesiol 2010; 59: 411-415)
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    Hypersensitivity reactions that might occur during anesthesia, 
i.e., anaphylaxis and anaphylactoid reaction, have been 
reported to have a variable degree of the incidence depending 
on the authors. But it has been reported to be approximately 
1/3,000-20,000 [1,2] and its mortality has been reported to be 
3-6% [1]. Of the drugs which are used for anesthesia, muscle 
relaxants have the highest frequency of inducing anaphylaxis. 
In addition, such substances as latex or antibiotics can also 
induce the occurrence of anaphylaxis [3]. On the other hand, 
the occurrence of anaphylaxis due to anesthetic agents has been 
frequently reported in men in their fifties and women in their 
forties. In pediatric patients aged ten years or younger, it occurs 
to such a rare extent as <4% of total cases of anaphylaxis [3]. 
    In the mid-1990s, rocuronium bromide (one of the non-
depolarizing aminosteroid muscle relaxants with a short action 
time) has been introduced in a clinical setting. As described 
here, according to the increased use of rocuronium, the occu-
rrence of rocuronium anaphylaxis has also been reported to rise 
[1,4]. Also in Korea, two cases of rocuronium anaphylaxis have 
been reported up to present [5,6]. But most of these cases have 
been reported to occur in middle-aged and elderly people. We 
experienced a case of anaphylaxis occurring due to rocuronium 
during anesthesia in a 33-month-old pediatric patient. To our 
knowledge, this is the youngest pediatric case of rocuronium-
induced anaphylaxis. 
Case Report
    A 33-month-old female weighed 15 kg visited us with chief 
complaints of deep flame burn with a 38% body surface area of 
grade 2 and 3 in such areas as face, body trunk, and both arms. 
The patient had no past history of recent upper respiratory 412 www.ekja.org
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tract infection, asthma, atopy, and allergic reactions to foods 
or drugs. On physical examination, the patient had no notable 
findings other than burn injury. On admission, the patient 
was transferred to an operating room for emergency care and 
then intravenously given thiopental sodium 80 mg. The patient 
received manual ventilation using N2O/O2 and sevoflurane. 
Without the administration of muscle relaxants, the patient 
underwent endotracheal intubation using an endotracheal tube 
with an inner diameter of 4.0 mm. Then, the patient underwent 
central venous, arterial, and urinary catheterization. This was 
followed by wound disinfection and dressing. At this time, the 
total anesthetic time was 60 minutes. The systolic and diastolic 
pressures were 90-100 mmHg and 45-60 mmHg, respectively, 
and the heart rate was 110-135 beats/min. Pulse oxymetry 
saturation (SPO2) was maintained at 100%. Thereafter, the 
patient was transferred to an intensive care unit (ICU) while 
having an endotracheal tube removed following a recovery of 
the mental alertness. Then, the patient underwent an intensive 
care through wound disinfection and fluid therapy.
    Three days later, the patient was supposed to escharectomy 
and cadaver skin graft under general anesthesia and then 
transferred to an operating room. The preoperative vital signs 
and routine laboratory results were within normal limits. 
To induce the anesthesia, following the pure oxygenation, 
propofol 30 mg and rocuronium bromide 10 mg (Esmeron, 
Hanhwa Pharmaceuticals Corp., Korea) were intravenously 
injected. Approximately 1 minute after the administration 
of rocuronium, i.e., immediately before the endotracheal 
intubation, the resistance was perceived at a reservoir bag. 
Meanwhile, SPO2 was abruptly decreased up to 84%. The heart 
rate was increased up to 170 beats/min. This was followed by 
an endotracheal intubation. At this time, the systolic pressure 
by an arterial catheter was decreased to 50-60 mmHg. On 
auscultation, the secretion sound was heard from the lung. 
The airway pressure was increased up to 30 cmH2O, based on 
which the abnormal location of an endotracheal tube or its 
obstruction was suspected. Following removal of endotracheal 
tube, the endotracheal intubation was performed again with 
the use of an endotracheal tube with an inner diameter of 4.5 
mm. To increase the blood pressure, the fluid was promptly 
administered at a rate of 150 ml/hr. Meanwhile, 100% oxygen 
was also administered and ephedrine 4 mg was administered 
twice. Following this, the systolic blood pressure was elevated to 
110 mmHg, however, hypoxia and a tachycardia of >170 beats/
min were continued. On arterial blood gas analysis, there were 
such measurements as pH 7.223, PCO2 51.9 mmHg, PO2 75.2 
mmHg and BE -7.1 mmol/L. The patient was transferred to 
ICU and the mechanical ventilation was performed by using 
midazolam and vecuronium for sedation. As soon as the patient 
reached ICU, the patient received a chest X-ray. According 
to this, the patient had findings suggestive of the pulmonary 
edema accompanying a shadow in both lungs (Fig. 1). Three 
days following an ICU treatment, the patient was found to have 
improved pulmonary edema. Then, the patient was transferred 
to an operation room in order to take the planned surgery 
in such a condition that an endotracheal tube was left. For 
anesthesia, the spontaneous respiration was maintained using 
N2O/O2 and sevoflurane with intermittent manually assisted 
ventilation. During the escharectomy on the abdominal area, 
the abdominal mobility due to a spontaneous respiration was 
severe. For the relaxation of abdominal msucles, the patient 
received an intravenous injection of rocuronium 10 mg. 
Approximately 2 minutes following an intravenous injection of 
rocuronium, without the abnormality of respiratory circuit, the 
airway pressure was increased. Meanwhile, SPO2 was decreased 
up to 75%. The systolic pressure was decreased to 40-50 mmHg. 
On arterial blood gas analysis, there were such measurements 
as pH 7.351, PCO2 41.1 mmHg, PO2 49.7 mmHg and BE -3.1 
mmol/L. Along with the administration of fluids, ephedrine 4 
mg was intravenously injected twice. With the maintenance of 
Fig. 1. Preoperative chest X-ray reveals 
unremarkable (left). Chest X-ray taken 
immediately after hypersensitivity reac-
tion showes pulmonary edema with ill-
defined hazziness at both lung, especially 
perihilar area, and accentuation of 
bronchovascular markings at both lung, 
especially perihilar area (right).413 www.ekja.org
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anesthesia using sevoflurane, N2O was discontinued and 100% 
oxygen was administered. Hypotension and hypoxia (SPO2: 
approximately 75%) were persistently present. Accordingly, 1 : 
1,000 epinephrine 0.15 mg was intramuscularly administered. 
Thereafter, the tachycardia was persistently present. Besides, 
the blood pressure and SPO2 were recovered. At this time, there 
were such measurements as pH 7.329, PCO2 42.9 mmHg, PO2 
124.3 mmHg and BE -3.9 mmol/L. A surgery was performed as 
planned. Intraoperatively, the cumulative packed red cells were 
administered at a volume of 80 ml. The total anesthetic time 
was 115 minutes. Immediately before a surgery was completed, 
dexamethasone 0.5 mg was administered. With an intravenous 
injection of neostigmine 1 mg and atropine 0.2 mg, the 
spontaneous respiration was recovered. Following the removal 
of an endotracheal tube, the recovery of mental alertness was 
confirmed. Then, the patient was transferred to ICU. Thirteen 
days later, the secondary escharectomy was planned. At this 
time, without the administration of muscle relaxants, the 
anesthesia was induced using propofol. Then, with the use 
of N2O/O2 and sevoflurane, the anesthesia was maintained. 
Thereafter, after the additional escharectomy was performed six 
times with volatile induction and maintenance of anesthesia 
with sevoflurane without muscle relaxants, skin graft was done. 
Two months and the extra ten days following an outpatient visit, 
the patient was discharged without notable complications. 
Discussion
    We experienced a case in which anaphylaxis was strongly 
suspected based on the findings that hypotension, tachycardia 
and hypoxia due to the use of rocuronium which was used for 
general anesthesia twice in a 33-month-old pediatric patient. 
Two types of immediate hypersensitivity reactions including 
anaphylaxis and anaphylactoid reaction are classified according 
to the involvement of such antibodies as immuoglobulin E (IgE). 
But it is not easy to make a differential diagnosis of these two 
reactions based on the clinical symptoms. Instead, they can be 
classified according to skin test or biologic test. In association 
with this, Mertes et al. [7] reported that it would be desirable 
to use such terms as anaphylactoid reaction in cases in which 
a diagnosis of immunological mechanisms was not made 
through an allergic test. In the present case, parents refused 
to take skin test for the patient. Therefore, due to a lack of the 
immediate biological test, the current case would correspond to 
the anaphylactoid reaction.
    In regard to most cases of the allergy occurring during 
anesthesia, i.e., acute hypersensitivity reaction, grade-2 
responses (non-life-threatening skin reaction, hypotension 
accompanying tachycardia, coughing or the difficulty of 
mechanical respiration) or grade-3 responses (life-threatening 
cardiovascular collapse, bradycardia or tachycardia and 
severe bronchospasm) account for approximately 85% of total 
cases [3]. The current case is the one that is suspected to be 
grade-2 or grade-3 anaphylaxis occurring due to rocuronium 
in a 33-month-old pediatric patient. To make an accurate 
diagnosis of anaphylaxis or anaphylactoid reaction, in addition 
to clinical symptoms, the concentrations of tryptase, histmaine 
or IgE which are present in the blood should be measured. 
Otherwise, after several weeks following the occurrence of 
allergic reactions, skin prick test or intradermal test should be 
performed [1,8]. Skin reactions occurring during the allergic 
responses due to drugs may be manifested as urticaria, edema, 
pruritis, thermal sensation and red spots. In the current case, 
however, these skin reactions were not perceived because of a 
burn injury. In addition, in the current case, at the time of onset 
of symptoms, the life saving treatment of child was considered 
to be important. Accordingly, the blood test for anaphylaxis 
could not be performed. However, at two anesthetic sessions, 
tachycardia, hypotension and hypoxia occurred identically 
within 2 minutes immediately after rocuronium was admini-
stered. Thereafter, during the other seven sessions of anesthesia 
for which rocuronium was not used, these symptoms did not 
occur. In this regard, anaphylaxis due to rocuronium could be 
powerfully suspected. 
    On the other hand, propofol may also cause the occurrence 
of anaphylaxis [9,10]. In the first onset of case, propofol and 
rocuronium were concurrently used. In the second onset of 
case, without using propofol, rocuronium was solely used. 
Besides, thereafter, in the anesthetic sessions where propofol 
was used but rocuronium was not used, these responses did 
not occur. Based on these findings, in the current case, the 
possibility for anaphylaxis due to propofol could be ruled out. 
    Anaphylaxis occurring during anesthesia occurs at a 
frequency which is approximately four times higher in men than 
women [8]. In regard to the age, it occurs the most frequently in 
people in their forties. The occurrence in pediatric patients aged 
ten years or younger has been rarely reported at a frequency 
which is lower than 4% of total cases of anaphylaxis [3]. Muscle 
relaxants are the most common drugs that cause the occurrence 
of anaphylaxis to a life-threatening extent during anesthesia, 
which account for approximately 50-70% of causes which are 
responsible for anaphylaxis occurring during ansethesia [11,12]. 
According to the reports made by Laxenaire et al. [3] about 
anaphylaxis which occurred during anesthesia for two years, 
anaphylaxis occurring due to muscle relaxants occurred the 
most frequently in people aged ten years or younger. Besides, 
it also occurred the most frequently in women aged in their 
thirties. In cases of rocuronium, however, there are extremely 
rare cases in which anaphylaxis occurred in a 33-month-
old pediatric patient as shown in the present case. Clinical 414 www.ekja.org
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characteristics due to rocuronium are mainly classified into two 
types: cardiovascular collapse and bronchospasm [1]. Generally 
in cases in which bronchospasm occurred due to anaphylaxis, 
due to the actions of alpha-1 elevating the blood pressure and 
those of beta-2 relaxing the bronchial smooth muscles, the 
immediate administration of epinephrine is important. Besides, 
in cases of cardiovascular collapse due to anaphylaxis, fluid 
supply is generally done and epinephrine and phenylephrine 
are administered. In cases which are refractory to these 
treatments, the administration of vasopressin could be of help 
[5]. Hypotension due to anaphylaxis cannot be well responded 
to ephedrine. In the current case, in the first onset of symptoms, 
the resistance was perceived during manual ventilation using 
a mask prior to endotracheal intubation. This indicates that 
there is a possibility for respiratory tract obstruction such as 
the upper airway obstruction, laryngospasm or bronchospasm. 
Thereafter, immediately after an endotracheal intubation was 
performed, the respiratory tract pressure was increased. The 
ventilation accompanying the mobility of chest was possible. 
It is therefore assumed that there is a remote possibility for the 
occurrence of bronchospasm. On the other hand, in the second 
onset of anaphylaxis, in such a condition that an endotracheal 
tube was placed, hypotension and increase in airway pressure 
occurred during surgery. Based on these findings, the possibility 
for bronchospasm is suspected. This is immediately responded 
to epinephrine. 
    Due to the increased permeability of capillary during the 
occurrence of anaphylaxis, the plasma volume is abruptly 
increased. A massive amount of fluid therapy might also be 
essential in this case. Owing to this, the edema might occur 
to the lung or respiratory tract. Also in the current case, 
following the first onset of anaphylaxis, on chest radiography 
which was performed in ICU setting, there was a finding that 
is suggestive of pulmonary edema. This might be due to the 
increased permeability of pulmonary capillary vessels because 
of anaphylaxis. Pulmonary edema occurring in the current 
case was recovered to the normal status after two days. But we 
assumed the possibility that pulmonary edema might originate 
from the negative pressure of respiratory tract. At the time, 
we could not speculate the possibility for anaphylaxis due to 
rocuronium. 
    On the other hand, rocuronium is an amino-steroid non-
depolarizing muscle relaxant whose pharmacological 
characteristics are similar to those of vecuronium. In cases of 
allergic reactions due to rocuronium, there might be cross-
reactions with other types of steroid non-depolarizing muscle 
relaxants. In particular, aminosteroid muscle relaxants have 
a higher prevalence of the cross-reactions as compared with 
benzilisoquinoline-derived muscle relaxants [13]. These muscle 
relaxants commonly have tetra-positively charged ammonium 
ion (NH4
+) as an antigenic determinant. Due to this chemical 
structure, the cross-reaction can occur. This should therefore be 
confirmed [14]. In the current case, however, the anaphylaxis 
occurred due to rocuronium during anesthesia. Following the 
use of vecuronium which was used for mechanical ventilation 
at an ICU, however, no anaphylaxis occurred. Accordingly, the 
possibility for cross-reactions between the two drugs was ruled 
out in the present case.
    Generally in pediatric patients, anaphylaxis rarely occurs 
during anesthesia. We experienced a case in which rocuronium-
induced grade-2 or grade-3 anaphylaxis was strongly suspected 
following two sessions of general anesthesia in a 33-month-
old pediatric patient. Although the occurrence of rocuronium-
induced anaphylaxis has been reported more frequently than 
that due to vecuronium or pancuronium and less frequently 
than that due to succinylcholine [8], there is a tendency that the 
use of succinylcholine has recently been decreased and that of 
rocuronium has been increased. Owing to this, the occurrence 
of rocuronium-induced anaphylaxis may be increased. On the 
other hand, the use of muscle relaxants can make it easier to 
perform an endotracheal intubation and it can also reduce the 
demand on major anesthetic agents. It is also advantageous that 
the postoperative complications associated with the respiratory 
tract can be reduced. But anesthesiologists can consider the 
methods for reducing risks of developing fatal anaphylaxis 
due to muscle relaxants by performing a laryngeal mask or an 
endotracheal intubation without the administration of muscle 
relaxants such as rocuronium.
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